THERAPEUTIC CUT-OFF OF INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

被引：0
|
作者：
Nagore, D. [1 ]
Ruiz del Agua, A. [1 ]
Pascual, J. [1 ]
Llinares-Tello, F. [2 ]
Herreros, B. [3 ]
Martinez, A. [1 ]
Martin, S. [1 ,4 ]
Navarro, R. [5 ]
机构：
[1] Progenika, R&D, Derio, Spain
[2] Hosp Marina Baixa, Clin Anal, Villajoyosa, Spain
[3] Hosp Marina Baixa, Digest Dis, Villajoyosa, Spain
[4] Univ Basque Country UPV EHU, Sch Med & Dent, Zabalduz Scholarship Programme, Dept Physiol, Leioa, Spain
[5] Univ Basque Country UPV EHU, Sch Med & Dent, Dept Physiol, Leioa, Spain
来源：
GUT | 2015年 / 64卷
关键词：
D O I：
10.1136/gutjnl-2015-309861.202
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PTU-087
引用
收藏
页码：A99 / A99
页数：1
相关论文
共 50 条
  • [31] BASDAI cut-off values corresponding to ASDAS cut-off values
    Kwon, Oh Chan
    Park, Min-Chan
    RHEUMATOLOGY, 2022, 61 (06) : 2369 - 2374
  • [32] Infliximab infusion time in patients with inflammatory bowel diseases: Is longer really safer?
    Belhassan, Mehdi
    Zeitoun, Jean-David
    Lefevre, Jeremie H.
    Charachon, Antoine
    Amiot, Aurelien
    Le Baleur, Yann
    Sobhani, Iradj
    Delchier, Jean-Charles
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2013, 37 (02) : 189 - 192
  • [33] Chronic inflammatory Bowel Diseases - Infliximab seems to be safe
    Weiss, Johannes
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (11):
  • [34] Infliximab in pediatric inflammatory bowel diseases: the Geneva experience
    Mueller, P.
    Rivier, A. Giroud
    Tempia-Schaeppi, M.
    Belli, D. C.
    SWISS MEDICAL WEEKLY, 2008, 138 : 41S - 41S
  • [35] Infliximab and amyloidosis secondary to inflammatory bowel diseases - Reply
    Casellas, F
    MEDICINA CLINICA, 2005, 124 (19): : 758 - 758
  • [36] Predictive Factors of Response to Infliximab in Inflammatory Bowel Diseases
    Bourrier, Anne
    Seksik, Philippe
    Sokol, Harry
    Johanet, Catherine
    Nion-Larmurier, Isabelle
    Beaugerie, Laurent
    Cosnes, Jacques
    GASTROENTEROLOGY, 2010, 138 (05) : S688 - S688
  • [37] Pharmacokinetics of Infliximab and Reduction of Treatment for Inflammatory Bowel Diseases
    Nicolas Williet
    Stephane Paul
    Laurent Peyrin-Biroulet
    Xavier Roblin
    Digestive Diseases and Sciences, 2016, 61 : 990 - 995
  • [38] Pharmacokinetics of Infliximab and Reduction of Treatment for Inflammatory Bowel Diseases
    Williet, Nicolas
    Paul, Stephane
    Peyrin-Biroulet, Laurent
    Roblin, Xavier
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (04) : 990 - 995
  • [39] CUT-OFF THE JOINT
    不详
    ECONOMIST, 1964, 210 (10): : 892 - 893
  • [40] Where to "cut-off"?
    Halicka, H. Dorota
    CYTOMETRY PART A, 2018, 93A (11) : 1092 - 1093
12345